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Physiology and pathophysiology of myocardial perfusion
regulation and of myocardial perfusion reserve. Because
of the high energy demands of myocardial contraction, the
heart is critically dependent on oxidative metabolism, and
insufficient myocardial oxygen delivery (i.e., ischemia) results
almost instantaneously in contractile and electrical dysfunction.
Because myocardial oxygen extraction in the blood is already
near maximal under resting conditions, myocardial perfusion is
strongly correlated with myocardial oxygen consumption,
and the principal mechanism for increasing oxygen delivery
to the heart is by increasing myocardial perfusion (1).
See page 1546
Under resting conditions, myocardial perfusion is autoregu-
lated, thus independent of driving arterial pressure and
adapted according to myocardial oxygen demand. This
matching of perfusion with oxygen requirements occurs by
control of myotonic tone of resistive pre-arterioles, which
reduce capillary pressure and regulate perfusion to the
required level. When myocardial oxygen demand increases
due to higher cardiac workload, such as during exercise, the
pre-arterioles relax under the influence of endothelial vaso-
dilators, allowing perfusion to increase to meet higher
oxygen demand. The magnitude of maximal perfusion
increase during exercise or vasodilation is termed myocardial
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contents of this paper to disclose.perfusion reserve (MPR). It is measured as the ratio of
perfusion during maximal vasodilation, achieved by infusion
of direct or indirect adenosine agonists, to resting perfusion,
and averages approximately 3 to 5 in normal myocardium.
Presence of epicardial coronary stenosis results in arterial
pressure drop downstream of the stenosis. Under resting
conditions, reduction of pre-arteriolar resistance can com-
pensate for this drop in arterial pressure, allowing capillary
pressure and myocardial perfusion to remain normal, if
stenosis severity is not too severe. However, this limits the
ability to increase maximal perfusion during exercise or
stress (2). Therefore, MPR decreases when stenosis severity
increases beyond 50% luminal diameter reduction (3), yet
with a wide variation between epicardial coronary stenosis
severity and MPR measured in vivo (4). Indeed MPR
depends not only on trans-stenotic pressure gradient and
thus stenosis severity but even more on the ability of the
pre-arterioles to dilate. Endothelial or microvascular dys-
function due to smoking, hypertension, diabetes, or dys-
lipidemia might reduce pre-arteriolar function and thus
MPR independently of the presence of epicardial coronary
stenosis. Hence, the ability to quantitatively measure stress
myocardial perfusion and MPR would allow a more com-
prehensive understanding of chest pain syndromes in pa-
tients and, in particular, of microvascular dysfunction (5).
et such quantification of MPR is not readily available in
linical practice. Indeed it requires the ability to quantity
yocardial perfusion in absolute terms (i.e., in ml/min/g
issue) both during maximal vasodilation and at rest.
ow can myocardial perfusion and perfusion reserve be
uantified? In humans, positron emission tomography
PET) is currently considered the reference technique for
uantification of myocardial perfusion and MPR. Unlike
onventional nuclear imaging, PET has the unique ability to
easure absolute radiotracer concentrations, allowing the
stimation of absolute myocardial perfusion from dynamic
mages after bolus injection of either 15O-water, 13N-ammonia, or
82Rb (6). These tracers diffuse into the myocardium in direct
roportion to myocardial perfusion. 13N-ammonia is sub-
equently trapped by metabolization into 13N-glutamate.
he behavior of these tracers can thus be described by 2- or
-compartment models, respectively, and myocardial perfu-
ion can be estimated by fitting myocardial against blood
racer concentration curves or by a simplified graphical
pproach termed “Patlak analysis.” The main disadvantage
f PET is the short half-life of the radioisotopes, requiring
n onsite cyclotron or a 82Rb generator for tracer produc-
ion. Therefore, this technique has never seen widespread
linical usage.
Magnetic resonance perfusion imaging is more exten-
ively available and allows for dynamic cardiac first pass
erfusion imaging after injection of gadolinium (Gd)-based
ontrast agents with higher temporal and especially spatial
esolution than PET. It would thus be an ideal technique





































1557JACC Vol. 60, No. 16, 2012 Gerber
October 16, 2012:1556–7 Myocardial Perfusion Reserve by PET and MRIMPR. Yet it has several methodological shortcomings that
need to be overcome to allow quantitative measurements of
myocardial perfusion to be performed (7). Most impor-
tantly, magnetic resonance imaging (MRI) cannot directly
measure contrast agent concentration. Although signal in-
tensity increase on T1 weighted imaging sequences is
roughly proportional to Gd concentration at low concen-
tration, this relation becomes nonlinear for high Gd con-
centrations, resulting in tracer underestimation at high
concentrations, a problem occurring particularly in the
blood pool. To overcome this limitation, a double bolus
injection protocol was proposed, in which the blood tracer
curve is obtained from a first injection of diluted contrast
and the myocardial curve is obtained from a second injection
of more concentrated contrast (8). Another problem is that
the currently available contrast agents have incomplete first
pass extraction rate and variable extravascular distribution,
especially in infarcted or fibrotic tissue. Therefore kinetic
compartment models, such as used for PET, are less reliable
to quantify perfusion for MRI than for PET. A more robust
approach for quantification of myocardial perfusion by MRI
is deconvolution of the myocardial against the blood signal
intensity curve to a Fermi function tissue impulse response
curve (9). By this approach the value of the Fermi curve at
time t  0 provides the estimate of myocardial perfusion.
Contribution of article. Because of the difficulties of
quantifying myocardial perfusion by MRI, so far there have
been only a few studies evaluating the accuracy of MPR
measurements by MRI in humans with coronary artery
disease (CAD). Therefore, the study by Morton et al. (10)
in the present issue of the Journal makes an important
contribution to the field. It compared measurements of
absolute myocardial perfusion and of MPR by adenosine
stress-rest perfusion MRI with a double bolus injection
protocol and Fermi deconvolution against 13N-ammonia
ET with Patlak analysis in patients with suspected coro-
ary disease before coronary angiography. The study dem-
nstrated a good correlation between MPR estimates by
RI and PET, thereby validating the accuracy of MPR
easurements by this MRI technique. Interestingly, how-
ver, individual resting and stress myocardial perfusion
easurements did not correlate well among MRI and PET.
here could be different explanations to account for this.
irst, the MRI and PET studies were performed at different
imes, and myocardial perfusion might have varied physio-
ogically or due to changes in hemodynamic conditions over
ime. More likely, however, these differences reflect dissim-
larities between the MRI and PET approaches to quantify
erfusion, in particular the distinct tracer properties, model
ssumptions, and fitting methods as well as parameter
onstraints. Accordingly, we observed earlier that absolute
yocardial perfusion estimates might differ for 2 PETracers employing different models (11). The inter-methodariation of myocardial perfusion likely cancelled out when
PR was computed from the ratio of rest to stress perfu-
ion, explaining why MPR correlated better than absolute
erfusion measurements among methods. Another impor-
ant finding of the study by Morton et al. was that MPR by
RI had similar high diagnostic accuracy to detect signif-
cant CAD by coronary angiography than MPR by PET.
his corroborates the clinical usefulness of adenosine stress
RI for noninvasive detection of CAD (12). Unfortu-
ately, however, due to the limited number of subjects, the
tudy could not demonstrate whether absolute quantifica-
ion of perfusion or of MPR improves diagnostic accuracy
or detection of CAD over visual analysis alone. Therefore
e must wait for further studies to evaluate whether the
fforts and intricacies required to quantify myocardial per-
usion and MPR by MRI can be warranted by better
iagnostic accuracy or greater prognostic value in patients
ith CAD.
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